Understanding T cell dysfunction & exhaustion in the context of solid tumors

Roisin McGuigan, Editor, Immuno–Oncology Insights, speaks to Gary Lee, Chief Scientific Officer, Lyell Immunopharma, about the barriers to effective cell therapy approaches in the solid tumor setting, and Lyell’s strategy for tackling them.

Please enter your email to access content Read now